Cupid shares surged 30% in the last six trading sessions, reaching a fresh 52‑week high of ₹344.75 on the National Stock Exchange on Wednesday, October 7. The rally follows the company’s announcement of strong business momentum in the second quarter of the current financial year. Investors reacted positively after Cupid indicated that revenue for the July‑September period would cross ₹200 crore. The stock has only closed lower on one of the six days, underscoring the bullish trend.

During intraday trading, Cupid shares advanced as much as 6.33%, and over the six‑session period the stock has only closed lower on a single day. The upward movement reflects sustained buying interest after the company’s positive outlook. The shares’ performance has outpaced the NIFTY Smallcap 100 index, which rose 0.6% on the day, placing Cupid among the top gainers in the index.

The company revised its FY27 revenue guidance to ₹800 crore and net profit guidance to ₹250 crore plus, citing sustained momentum across key business verticals and improved visibility in domestic and international markets. Cupid also confirmed that it expects revenue to exceed ₹200 crore in the July‑September quarter. These updates have bolstered investor confidence, contributing to the recent share price rally.

In the second quarter, Cupid approved conversion of up to 30 lakh warrants of Baazar Style Retail Limited into an equivalent number of equity shares at ₹328.25 per share. The company also received in‑principal approval for a manufacturing venture in South Africa, adopting an asset‑light model that combines Cupid’s manufacturing expertise with local partner support. The initiative aims to create a platform for institutional procurement and wider African market expansion, supporting local manufacturing and providing a base for expansion across Africa and international markets. Additionally, Cupid strengthened its strategic healthcare partnership with GII Healthcare Investment Limited through a $5 million follow‑on investment, and it continues to expand its FMCG portfolio and manufacturing capabilities for both B2B healthcare and domestic consumer businesses.

Looking ahead, Cupid plans to scale domestic FMCG distribution to deepen its presence across modern trade, general trade and pharmacy channels. The Nashik‑based company will operationalise the Palava manufacturing facility to enhance production capacity, flexibility and supply capabilities for domestic and international markets. As of 11:2 am, Cupid shares traded 6.3% higher at ₹344.65, outperforming the NIFTY Smallcap 100 index which was up 0.6%, and the stock was among the top gainers in the index.